This morning, Novartis CEO Joe Jimenez announced fourth quarter and full year 2017 results. In his remarks Jimenez said: “It was a landmark year for innovation resulting in a rich late-stage pipeline. With several key launches on the horizon and our new operating model in place, Novartis is poised for sustainable growth.”
Vas Narasimhan, designated CEO from February 1, commented: “I want to thank Joe and the Board for their leadership and guidance as I transition to my new role. I feel privileged to lead Novartis at this exciting time.”
2017 At A Glance
![Novartis 2017 Financial Results Novartis 2017 Financial Results](/sites/novartis_com/files/styles/crop_freeform/public/2021-07/novartis-media-landing-page-numbers-image.jpg.webp?itok=OiRZj8Pj)
Download the presentation
Media Presentation (PDF 10 MB)
Annual Report 2017
The Novartis Annual Report 2017 reviews the company’s strategy and annual performance.
Visit the Annual Report
Novartis Pipeline
For a detailed review of selected projects in confirmatory development, download the complete Novartis Pipeline (PDF 92 KB) as of December 31, 2017.
Learn more about our Clinical Pipeline